Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

2009 • 78,446 citations

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

2009 • 44,660 citations

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

2009 • 24,111 citations

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2010 • 21,372 citations

Introduction to Meta‐Analysis

2009 • 11,635 citations

Introduction to Meta‐Analysis

2021 • 8,727 citations

Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions

2004 • 1,703 citations

Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment

2010 • 1,044 citations

Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis

1999 • 940 citations

Mycotoxins and human disease: a largely ignored global health issue

2009 • 874 citations

IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene

2002 • 779 citations

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

1992 • 723 citations

A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

1994 • 668 citations

Workgroup Report: Public Health Strategies for Reducing Aflatoxin Exposure in Developing Countries

2006 • 506 citations

Confidence Limits Made Easy: Interval Estimation Using a Substitution Method

1998 • 272 citations

Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

1996 • 252 citations

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

2002 • 227 citations

Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia

2000 • 190 citations

249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma

2005 • 173 citations

p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

1997 • 172 citations

Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma

1996 • 170 citations

Climate change impacts on mycotoxin risks in US maize

2011 • 156 citations

Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan

2009 • 123 citations

Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan

1997 • 112 citations

Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.

1996 • 110 citations

Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan

2001 • 108 citations

Confounding and Bias in the Attributable Fraction

2010 • 87 citations

In Vitro Recapitulating of TP53 Mutagenesis in Hepatocellular Carcinoma Associated With Dietary Aflatoxin B1 Exposure

2009 • 82 citations

Population-Attributable Risk of Dietary Aflatoxins and Hepatitis B Virus Infection with Respect to Hepatocellular Carcinoma

2004 • 71 citations

Codon 249 mutation in exon 7 ofp53gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China

2003 • 60 citations

XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk

2009 • 59 citations

TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, China

2009 • 58 citations

Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case-control study in Sudan.

2001 • 50 citations

A case-control study of risk factors for hepatocellular carcinoma in Henan, China.

1998 • 45 citations

Cooperation of tumor‐derived HBx mutants and p53‐249^ser mutant in regulating cell proliferation, anchorage‐independent growth and aneuploidy in a telomerase‐immortalized normal human hepatocyte‐derived cell line

2009 • 41 citations

Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan

2011 • 27 citations

Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival

2011 • 23 citations